FDA tells ADHD makers to warn patients of risks
Wed, 21 Feb 2007 04:09 PM EST
... WASHINGTON (Reuters) - All manufacturers of attention deficit drugs should alert patients to possible cardiovascular and psychiatric risks from the medicines, U.S. health officials said on Wednesday. ...
Related Topics
- ADHD
- Maker's Diet
- Seizures (in about half of patients)
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Amniocentesis
- Tacrolimus ointment
- Smoking Cessation and Continued Risk in Cancer Patients
- Approximately one-half of patients with small tumors will get back useful hearing in the affected ear after surgery.
- Guanfacine
- Mammography
- Carcinogens
- Most people with small tumors will have no permanent paralysis of the face after surgery. However, about two-thirds of patients with large tumors will have some permanent facial weakness after surgery.
- Attention Deficit Hyperactivity Disorder (ADHD)
- Attention Deficit Hyperactivity (ADHD), Adult
- Pimecrolimus Cream 1%
- Dietary Guidelines
- Thalidomide
- Support Groups
- Amantadine

Not Signed In -

